<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nimodipine, now widely used for treatment and prevention of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebrovascular spasm</z:e>, is regarded as a safe drug </plain></SENT>
<SENT sid="1" pm="."><plain>Despite a preferential action on cerebral vessels, there is clinical and experimental evidence of effects on systemic vascular and intestinal smooth muscle cells </plain></SENT>
<SENT sid="2" pm="."><plain>Gastro-intestinal side-effects, however, have not been reported in clinical studies dealing with treatment of vasospasm following <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We report on a patient with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> who developed an <z:hpo ids='HP_0011009'>acute</z:hpo> life-threatening pseudo-obstruction of the colon, a variant of adynamic <z:hpo ids='HP_0002595'>ileus</z:hpo>, while being treated with intravenous nimodipine </plain></SENT>
<SENT sid="4" pm="."><plain>The relationship between this complication and calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> therapy is discussed and therapeutic strategies are presented </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that neurosurgeons and neurologists should be aware of calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi>--related <z:hpo ids='HP_0002595'>ileus</z:hpo> in patients treated with nimodipine </plain></SENT>
</text></document>